GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Q

Qingdao Vland Biotech 603739.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

11.71

-1.26%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Qingdao Vland Biotech

Its shares trade on Shanghai under the ticker 603739.SS. It has been listed since 16 January 2019. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.37bn and net income of CN¥69.8m. At that date it held total assets of CN¥3.04bn and shareholders' equity of CN¥1.78bn.

Qingdao Vland Biotech Co., Ltd. manufactures biotech products. The company is headquartered in Qingdao, Shandong. The company went IPO on 2019-01-16. The firm's main products are enzyme preparations, micro-ecology and animal health products, such as feed enzymes, industrial enzymes, food enzymes, plant micro-ecological preparations, veterinary chemicals and veterinary drugs. The firm's products are mainly used in the washing, textile, food, feed, paper, energy and pharmaceutical industries. The firm mainly distributes its products in China and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
16 Jan 2019
Employees
1,590

Leadership

Pay as last reported

  • Mr. Bingliang HuangChairman of the BoardCN¥360,700
  • Mr. Piyuan QiaoChief Financial OfficerCN¥680,700
  • Mr. Gang ChenGeneral Manager, DirectorCN¥1.1m
  • Mr. Yong JiangSecretary of the BoardCN¥436,700
  • Mr. Deqiang JiaDirectorCN¥300,700
  • Mr. Xiaocheng ZhangDirectorCN¥300,700
  • Ms. Xiaoming HongIndependent DirectorCN¥60,000
  • Mr. Yingting LinIndependent DirectorCN¥60,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Qingdao Vland Biotech employs 1,590 full-time employees in the Health Care sector.
  • The company's enzyme preparations are used in food, feed, and pharmaceutical industries.
  • Qingdao Vland Biotech's products are distributed in China and overseas markets.

Weaknesses

  • The company's main products include veterinary chemicals and veterinary drugs.
  • Qingdao Vland Biotech's business is limited to enzyme preparations and micro-ecology.
  • The firm's products are mainly used in specific industries like textile and paper.

Opportunities

  • Qingdao Vland Biotech can expand into the growing global biotechnology market.
  • The company's enzyme preparations have potential in the food and feed industries.
  • Overseas markets offer growth opportunities for Qingdao Vland Biotech's products.

Threats

  • The company's reliance on enzyme preparations may limit market diversification.
  • Competition in the biotechnology sector could increase pressure on pricing.
  • Regulatory changes in China might affect the production of veterinary drugs.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.